These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
268 related articles for article (PubMed ID: 17709409)
1. Role of CD14 in responses to clinical isolates of Escherichia coli: effects of K1 capsule expression. Metkar S; Awasthi S; Denamur E; Kim KS; Gangloff SC; Teichberg S; Haziot A; Silver J; Goyert SM Infect Immun; 2007 Nov; 75(11):5415-24. PubMed ID: 17709409 [TBL] [Abstract][Full Text] [Related]
2. Escherichia coli K1-specific bacteriophage CUS-3 distribution and function in phase-variable capsular polysialic acid O acetylation. King MR; Vimr RP; Steenbergen SM; Spanjaard L; Plunkett G; Blattner FR; Vimr ER J Bacteriol; 2007 Sep; 189(17):6447-56. PubMed ID: 17601779 [TBL] [Abstract][Full Text] [Related]
3. The K1 capsule is the critical determinant in the development of Escherichia coli meningitis in the rat. Kim KS; Itabashi H; Gemski P; Sadoff J; Warren RL; Cross AS J Clin Invest; 1992 Sep; 90(3):897-905. PubMed ID: 1326000 [TBL] [Abstract][Full Text] [Related]
4. CD14 inhibition efficiently attenuates early inflammatory and hemostatic responses in Escherichia coli sepsis in pigs. Thorgersen EB; Hellerud BC; Nielsen EW; Barratt-Due A; Fure H; Lindstad JK; Pharo A; Fosse E; Tønnessen TI; Johansen HT; Castellheim A; Mollnes TE FASEB J; 2010 Mar; 24(3):712-22. PubMed ID: 19841036 [TBL] [Abstract][Full Text] [Related]
5. CD14 plays no major role in shock induced by Staphylococcus aureus but down-regulates TNF-alpha production. Haziot A; Hijiya N; Schultz K; Zhang F; Gangloff SC; Goyert SM J Immunol; 1999 Apr; 162(8):4801-5. PubMed ID: 10202023 [TBL] [Abstract][Full Text] [Related]
6. The form variation of the capsular polysaccharide K1 is not a critical virulence factor of Escherichia coli in a neonatal mouse model of infection. Colino J; Outschoorn I Microb Pathog; 1999 Oct; 27(4):187-96. PubMed ID: 10502459 [TBL] [Abstract][Full Text] [Related]
7. A review: relation between invasiveness and the K1 capsular polysaccharide of Escherichia coli. Schiffer MS; Oliveira E; Glode MP; McCracken GH; Sarff LM; Robbins JB Pediatr Res; 1976 Feb; 10(2):82-7. PubMed ID: 1107953 [TBL] [Abstract][Full Text] [Related]
8. The importance of a lipopolysaccharide-initiated, cytokine-mediated host defense mechanism in mice against extraintestinally invasive Escherichia coli. Cross A; Asher L; Seguin M; Yuan L; Kelly N; Hammack C; Sadoff J; Gemski P J Clin Invest; 1995 Aug; 96(2):676-86. PubMed ID: 7635960 [TBL] [Abstract][Full Text] [Related]
9. Yang J; Ma W; Wu Y; Zhou H; Song S; Cao Y; Wang C; Liu X; Ren J; Duan J; Pei Z; Jin C Microbiol Spectr; 2021 Dec; 9(3):e0039921. PubMed ID: 34878295 [TBL] [Abstract][Full Text] [Related]
10. Effect of CD14 blockade in rabbits with Escherichia coli pneumonia and sepsis. Frevert CW; Matute-Bello G; Skerrett SJ; Goodman RB; Kajikawa O; Sittipunt C; Martin TR J Immunol; 2000 May; 164(10):5439-45. PubMed ID: 10799910 [TBL] [Abstract][Full Text] [Related]
11. The K1 capsular polysaccharide of Escherichia coli. Silver RP; Aaronson W; Vann WF Rev Infect Dis; 1988; 10 Suppl 2():S282-6. PubMed ID: 3055198 [TBL] [Abstract][Full Text] [Related]